|
EP3045169A1
|
|
Aqueous solution formulation, and manufacturing method for same
|
|
JP2005122750A
|
|
Method of generating database for searching new ligand compound from three-dimensional structure database
|
|
US2007042997A1
|
|
Medicament for treatment of dermal pigmentation
|
|
US2006229324A1
|
|
Quinazolin-4-one derivatives
|
|
JP2003325076A
|
|
Method for profiling action of compound on organism
|
|
AU1428602A
|
|
Method of profiling protein
|
|
US2002062155A1
|
|
Method for creating physiologically active compounds
|
|
WO9918440A1
|
|
Method of inferring three-dimensional structure of protein
|
|
WO9901409A1
|
|
Method for inferring protein functions with the use of ligand data base
|
|
EP1010681A1
|
|
Preparation method of physiologically active compound
|
|
CA2237872A1
|
|
Design method of physiologically active compound
|
|
EP0790567A1
|
|
Method of retrieving novel ligand compounds from three-dimensional structure database
|
|
JPH07133233A
|
|
Method of constructing molecular structure of ligand having physiological activity
|
|
WO9320525A1
|
|
Method of searching the structure of stable biopolymer-ligand molecule composite
|
|
JPH06309385A
|
|
Constructing method for molecular structure for ligand having bioactivity
|
